This is a summary of the European public assessment report (EPAR) for Ikervis. It explains how the Agency assessed the medicine to recommend its authorisation in the European Union and its conditions of use. It is not intended to provide practical advice on how to use Ikervis. For practical information about using Ikervis, patients should read the package leaflet or contact their doctor or pharmacist.
Therapeutic Indication
### Therapeutic indication Treatment of severe keratitis in adult patients with dry eye disease, which has not improved despite treatment with tear substitutes.
Therapeutic Area (MeSH)
ATC Code
S01XA18
ATC Item
ciclosporin
Pharmacotherapeutic Group
Ophthalmologicals
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| ciclosporin | N/A | 环孢素 |
EMA Name
Ikervis
Medicine Name
Ikervis
Aliases
N/A
